| Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia GL Uy, I Aldoss, MC Foster, PH Sayre, MJ Wieduwilt, AS Advani, ... Blood 137 (6), 751-762, 2021 | 152 | 2021 |
| Genetic variations and interrelationships in Vanilla planifolia and few related species as expressed by RAPD polymorphism D Minoo, VN Jayakumar, SS Veena, J Vimala, A Basha, KV Saji, ... Genetic Resources and Crop Evolution 55, 459-470, 2008 | 93 | 2008 |
| Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia J Vadakekolathu, MD Minden, T Hood, SE Church, S Reeder, H Altmann, ... Science translational medicine 12 (546), eaaz0463, 2020 | 92 | 2020 |
| TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML J Vadakekolathu, C Lai, S Reeder, SE Church, T Hood, A Lourdusamy, ... Blood advances 4 (20), 5011-5024, 2020 | 77 | 2020 |
| A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics N Harner-Foreman, J Vadakekolathu, SA Laversin, MG Mathieu, ... Scientific reports 7 (1), 40633, 2017 | 45 | 2017 |
| Immune-phenotyping and transcriptomic profiling of peripheral blood mononuclear cells from patients with breast cancer: identification of a 3 gene signature which predicts … GA Foulds, J Vadakekolathu, TMA Abdel-Fatah, D Nagarajan, S Reeder, ... Frontiers in immunology 9, 2028, 2018 | 40 | 2018 |
| Phase 1 cohort expansion of flotetuzumab, a CD123× CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML) GL Uy, MP Rettig, N Vey, J Godwin, MC Foster, DA Rizzieri, ML Arellano, ... Blood 132, 764, 2018 | 39 | 2018 |
| A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study S Wagner, J Vadakekolathu, SK Tasian, H Altmann, M Bornhäuser, ... Blood advances 3 (8), 1330-1346, 2019 | 33 | 2019 |
| Novel prostate acid phosphatase‐based peptide vaccination strategy induces antigen‐specific T‐cell responses and limits tumour growth in mice JMS Saif, J Vadakekolathu, SS Rane, D McDonald, M Ahmad, M Mathieu, ... European journal of immunology 44 (4), 994-1004, 2014 | 32 | 2014 |
| MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer J Vadakekolathu, SIK Al-Juboori, C Johnson, A Schneider, ME Buczek, ... Cell death & disease 9 (3), 344, 2018 | 31 | 2018 |
| T-cell manipulation strategies to prevent graft-versus-host disease in haploidentical stem cell transplantation J Vadakekolathu, S Rutella Biomedicines 5 (2), 33, 2017 | 29 | 2017 |
| SARS-CoV-2 infection induces psoriatic arthritis flares and enthesis resident plasmacytoid dendritic cell type-1 interferon inhibition by JAK antagonism offer novel … Q Zhou, J Vadakekolathu, A Watad, K Sharif, T Russell, H Rowe, A Khan, ... Frontiers in Immunology 12, 635018, 2021 | 24 | 2021 |
| IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer C Tulotta, DV Lefley, CK Moore, AE Amariutei, AR Spicer-Hadlington, ... NPJ Breast Cancer 7 (1), 95, 2021 | 19 | 2021 |
| Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without … R Alves, SEB McArdle, J Vadakekolathu, AC Gonçalves, ... Journal of Translational Medicine 18 (1), 1-15, 2020 | 17 | 2020 |
| PYK2 promotes HER2-positive breast cancer invasion SIK Al-Juboori, J Vadakekolathu, S Idri, S Wagner, D Zafeiris, ... Journal of Experimental & Clinical Cancer Research 38 (1), 1-14, 2019 | 17 | 2019 |
| Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary TumorsMacrophage Response to Oncolytic Viruses in Mammary Tumors A Kwan, N Winder, E Atkinson, H Al-Janabi, RJ Allen, R Hughes, ... Molecular Cancer Therapeutics 20 (3), 589-601, 2021 | 13 | 2021 |
| Flotetuzumab, an investigational CD123 x CD3 bispecific Dart® protein, in salvage therapy for primary refractory and early relapsed acute myeloid leukemia (AML) patients GL Uy, I Aldoss, MC Foster, DA Sallman, KL Sweet, DA Rizzieri, PH Sayre, ... Blood 134, 733, 2019 | 13 | 2019 |
| Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123× CD3 bispecific DART® molecule, in patients with relapsed/refractory acute myeloid leukemia S Rutella, SE Church, J Vadakekolathu, E Viboch, AH Sullivan, T Hood, ... Blood 132, 444, 2018 | 12 | 2018 |
| Genetic diversity and phylogenetic relationship among small cardamom (Elettaria cardamomum Maton.) cultivars and related genera using DNA markers KN Babu, VN Jayakumar, M Divakaran, MN Venugopal, MR Sudarshan, ... International Journal of Innovative Horticulture 1 (1), 47-56, 2012 | 12 | 2012 |
| Identification and characterisation of NANOG+/OCT-4high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines RM Balahmar, DJ Boocock, C Coveney, S Ray, J Vadakekolathu, ... Oncotarget 9 (6), 7054, 2018 | 11 | 2018 |
Sergio Rutella, MD PhD, FRCPath, FR...Nottingham Trent UniversityGeverifieerd e-mailadres voor ntu.ac.uk
